A Split-Face, Single-Blind, Study Assessing the Use of a Topical Antioxidant Containing Silymarin With A Series of 1726nm Laser Procedures to Reduce Sebum Production
Status: Recruiting
Location: See location...
Intervention Type: Device, Drug
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
This is a split-face, single-blind study assessing the use of an antioxidant serum with a series of acne laser treatments to reduce sebum production in healthy male and female subjects between the ages of 18 and 65 years, inclusive, with Fitzpatrick skin types I-VI.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 65
Healthy Volunteers: t
View:
⁃ Subjects must meet all the inclusion criteria in order to be eligible for this study:
• Healthy male and female subjects aged between 18 and 65 years, inclusive of all Fitzpatrick Skin Types (I-VI)
• Self-perceived oily skin. Subject must answer Yes to the question Do you have an oily complexion?
• Mild to moderate acne (2-3) based on IGA
• No known medical conditions that, in the Investigator's opinion may interfere with study participation
• Female subjects of childbearing potential must be on and remain on a study-specified stable form of birth control throughout participation in study (See Section 6.1.1)
• Willingness to cooperate and participate by following study requirements
• Individuals must sign an informed consent and a photography consent
14 day application of topical antioxidant serum containing Silymarin CF~Subjects will be given study drug and instructed to topically apply to the treatment area, the respectively randomized half of the face, once daily for 14 consecutive days.
14 day application of topical antioxidant serum containing Silymarin CF~Subjects will be given study drug and instructed to topically apply to the treatment area, the respectively randomized half of the face, once daily for 14 consecutive days.